Market revenue in 2023 | USD 872.3 million |
Market revenue in 2030 | USD 1,440.7 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.64% in 2023. Horizon Databook has segmented the Europe real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of this region can be attributed to increase in hospital visits due to the rising prevalence of chronic & infectious diseases and the rapid rise in geriatric population across the region. Major market players are focused on various business strategies, such as product launches, to expand their product portfolio and other initiatives.
For instance, ICON plc, based in Ireland, closed the acquisition of PRA Health Sciences for USD 12 billion and USD 80 per share in cash in July 2021. Apart from this, increasing R&D investments and rising demand for RWE solutions and RWD are anticipated to fuel market growth over the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account